OPEN APP
Home / Companies / News /  Serum Institute to increase Covishield production next month

The Serum Institute of India will raise production of the AstraZeneca COVID-19 vaccine to about 90 million doses in June from about 65 million a month now, a company spokesman told Reuters on Monday.

This came amid reports of shortage of COVID-19 vaccines in the country as flagged by several state governments.

India is currently using made-in-India vaccines -- Covishield manufactured by SII and Covaxin of Bharat Biotech -- for its COVID-19 vaccination programme. Russian Sputnik V is the third vaccine to get approval from the Drug Controller General of India (DCGI) for emergency use. (A

Catch all the Corporate news and Updates on Live Mint. Download The Mint News App to get Daily Market Updates & Live Business News.
More Less
Subscribe to Mint Newsletters
* Enter a valid email
* Thank you for subscribing to our newsletter.

Recommended For You

Trending Stocks

×
Get alerts on WhatsApp
Set Preferences My ReadsWatchlistFeedbackRedeem a Gift CardLogout